Figure 1.

The incidence rates of HPV16/18-related cervical cancer, HPV16/18-related CIN2/3, and HPV6/11-related genital warts among females and males by vaccination strategy during the next 100 years. We assumed that approximately 71% of cervical cancer cases were attributable to HPV 16 and 18, and 90% of genital warts cases were attributable to HPV 6 and 11 in Brazil.

Kawai et al. BMC Infectious Diseases 2012 12:250   doi:10.1186/1471-2334-12-250
Download authors' original image